← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2014Last known activity
Jan 1, 2017
Timeline
1970s
- Jul 31, 1970
fluorouracil— NDA Secondary Org
2000s
- Jan 1, 2007
Elorac, Inc.— Founded
2010s
- Apr 15, 2016
Gideon Pharmaceuticals— Acquired
Drugs by trial phase (8 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (6)
- NCT02811783Study directorPhase 3Jan 1, 2017
- NCT02811783Lead sponsorPhase 3Jan 1, 2017
- NCT02502669Study directorPhase 2Jul 1, 2015
- NCT02502669Lead sponsorPhase 2Jul 1, 2015
- NCT02251678Study directorPhase 1Sep 1, 2014
- NCT02251678Lead sponsorPhase 1Sep 1, 2014
Details
- Founded
- Vernon Hills, IL, US Jan 1, 2007
- Last known activity
- Jan 1, 2017